Table Of Contents
1. Introduction
1.1 Market Definition & Scope
1.2 Research Assumptions & Abbreviations
1.3 Research Methodology
2. Executive Summary
2.1 Market Snapshot
2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2021–2032
2.3 Market Size & Forecast, By Segmentation, 2021–2032
2.3.1 Market Size By Drug Type
2.3.2 Market Size By Mechanism of Action
2.3.3 Market Size By Distribution Channel
2.4 Market Share & Bps Analysis By Region, 2024
2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic
2.6 Industry CxO’s Perspective
3. Market Overview
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Key Market Trends
3.2 Industry PESTLE Analysis
3.3 Key Industry Forces (Porter’s) Impacting Market Growth
3.4 Industry Supply Chain Analysis
3.4.1 Raw Material Suppliers
3.4.2 Manufacturers
3.4.3 Distributors/Suppliers
3.4.4 Customers/End-Users
3.5 Industry Life Cycle Assessment
3.6 Parent Market Overview
3.7 Market Risk Assessment
4. Statistical Insights & Trends Reporting
4.1 Epidemiology & Obesity Prevalence Metrics
4.1.1 Global and regional obesity prevalence rates (%) by age group and gender
4.1.2 Percentage of overweight population eligible for pharmacological intervention (%)
4.1.3 Year-on-year growth (%) in obesity-related comorbidities (diabetes, hypertension, cardiovascular diseases)
4.2 Prescription & Adoption Trends
4.2.1 Share of patients using prescription drugs vs. OTC/supplements (%)
4.2.2 Adoption rate (%) of GLP-1 agonists, lipase inhibitors, and other novel drug classes
4.2.3 Year-on-year growth (%) in prescriptions for weight loss drugs across key regions
4.3 Efficacy & Clinical Outcome Metrics
4.3.1 Average weight reduction (%) achieved after 6–12 months of treatment by drug class
4.3.2 Discontinuation rate (%) due to side effects or lack of efficacy
4.3.3 Percentage of patients achieving ≥5% and ≥10% body weight reduction with drug therapy
4.4 Healthcare Spending & Cost Burden
4.4.1 Average annual treatment cost per patient (USD) for weight loss drugs
4.4.2 Share of healthcare expenditure (%) allocated to obesity management in major markets
4.4.3 Out-of-pocket expenditure (%) vs. insurance/reimbursement coverage for weight loss drugs
5. Weight Loss Drugs Market Segmental Analysis & Forecast, By Drug Type, 2021 – 2032, Value (USD Billion)
5.1 Introduction
5.2 Prescription Drugs
5.2.1 Key Trends
5.2.2 Market Size & Forecast, 2021 – 2032
5.3 Over-the-counter drugs (OTC)
5.3.1 Key Trends
5.3.2 Market Size & Forecast, 2021 – 2032
6. Weight Loss Drugs Market Segmental Analysis & Forecast, By Mechanism of Action, 2021 – 2032, Value (USD Billion)
6.1 Introduction
6.2 Appetite Suppressants
6.2.1 Key Trends
6.2.2 Market Size & Forecast, 2021 – 2032
6.3 Fat Absorption Inhibitors
6.3.1 Key Trends
6.3.2 Market Size & Forecast, 2021 – 2032
6.4 Combination Drugs
6.4.1 Key Trends
6.4.2 Market Size & Forecast, 2021 – 2032
7. Weight Loss Drugs Market Segmental Analysis & Forecast, By Distribution Channel, 2021 – 2032, Value (USD Billion)
7.1 Introduction
7.2 Hospital Pharmacies
7.2.1 Key Trends
7.2.2 Market Size & Forecast, 2021 – 2032
7.3 Retail Pharmacies
7.3.1 Key Trends
7.3.2 Market Size & Forecast, 2021 – 2032
7.4 Online Pharmacies
7.4.1 Key Trends
7.4.2 Market Size & Forecast, 2021 – 2032
8. Weight Loss Drugs Market Segmental Analysis & Forecast By Region, 2021 – 2025, Value (USD Billion)
8.1 Introduction
8.2 North America
8.2.1 Key Trends
8.2.2 Weight Loss Drugs Market Size & Forecast, By Drug Type, 2021 – 2032
8.2.3 Weight Loss Drugs Market Size & Forecast, By Mechanism of Action, 2021 – 2032
8.2.4 Weight Loss Drugs Market Size & Forecast, By Distribution Channel, 2021 – 2032
8.2.5 Weight Loss Drugs Market Size & Forecast, By Country, 2021 – 2032
8.2.5.1 USA
8.2.5.1.1 Weight Loss Drugs Market Size & Forecast, By Drug Type, 2021 – 2032
8.2.5.1.2 Weight Loss Drugs Market Size & Forecast, By Mechanism of Action, 2021 – 2032
8.2.5.1.3 Weight Loss Drugs Market Size & Forecast, By Distribution Channel, 2021 – 2032
8.2.5.2 Canada
8.2.5.2.1 Weight Loss Drugs Market Size & Forecast, By Drug Type, 2021 – 2032
8.2.5.2.2 Weight Loss Drugs Market Size & Forecast, By Mechanism of Action, 2021 – 2032
8.2.5.2.3 Weight Loss Drugs Market Size & Forecast, By Distribution Channel, 2021 – 2032
8.3 Europe
8.3.1 Key Trends
8.3.2 Weight Loss Drugs Market Size & Forecast, By Drug Type, 2021 – 2032
8.3.3 Weight Loss Drugs Market Size & Forecast, By Mechanism of Action, 2021 – 2032
8.3.4 Weight Loss Drugs Market Size & Forecast, By Distribution Channel, 2021 – 2032
8.3.5 Weight Loss Drugs Market Size & Forecast, By Country, 2021 – 2032
8.3.5.1 Germany
8.3.5.1.1 Weight Loss Drugs Market Size & Forecast, By Drug Type, 2021 – 2032
8.3.5.1.2 Weight Loss Drugs Market Size & Forecast, By Mechanism of Action, 2021 – 2032
8.3.5.1.3 Weight Loss Drugs Market Size & Forecast, By Distribution Channel, 2021 – 2032
8.3.5.2 UK
8.3.5.2.1 Weight Loss Drugs Market Size & Forecast, By Drug Type, 2021 – 2032
8.3.5.2.2 Weight Loss Drugs Market Size & Forecast, By Mechanism of Action, 2021 – 2032
8.3.5.2.3 Weight Loss Drugs Market Size & Forecast, By Distribution Channel, 2021 – 2032
8.3.5.3 France
8.3.5.3.1 Weight Loss Drugs Market Size & Forecast, By Drug Type, 2021 – 2032
8.3.5.3.2 Weight Loss Drugs Market Size & Forecast, By Mechanism of Action, 2021 – 2032
8.3.5.3.3 Weight Loss Drugs Market Size & Forecast, By Distribution Channel, 2021 – 2032
8.3.5.4 Italy
8.3.5.4.1 Weight Loss Drugs Market Size & Forecast, By Drug Type, 2021 – 2032
8.3.5.4.2 Weight Loss Drugs Market Size & Forecast, By Mechanism of Action, 2021 – 2032
8.3.5.4.3 Weight Loss Drugs Market Size & Forecast, By Distribution Channel, 2021 – 2032
8.3.5.5 Spain
8.3.5.5.1 Weight Loss Drugs Market Size & Forecast, By Drug Type, 2021 – 2032
8.3.5.5.2 Weight Loss Drugs Market Size & Forecast, By Mechanism of Action, 2021 – 2032
8.3.5.5.3 Weight Loss Drugs Market Size & Forecast, By Distribution Channel, 2021 – 2032
8.3.5.6 Russia
8.3.5.6.1 Weight Loss Drugs Market Size & Forecast, By Drug Type, 2021 – 2032
8.3.5.6.2 Weight Loss Drugs Market Size & Forecast, By Mechanism of Action, 2021 – 2032
8.3.5.6.3 Weight Loss Drugs Market Size & Forecast, By Distribution Channel, 2021 – 2032
8.3.5.7 Poland
8.3.5.7.1 Weight Loss Drugs Market Size & Forecast, By Drug Type, 2021 – 2032
8.3.5.7.2 Weight Loss Drugs Market Size & Forecast, By Mechanism of Action, 2021 – 2032
8.3.5.7.3 Weight Loss Drugs Market Size & Forecast, By Distribution Channel, 2021 – 2032
8.3.5.8 Rest of Europe
8.3.5.8.1 Weight Loss Drugs Market Size & Forecast, By Drug Type, 2021 – 2032
8.3.5.8.2 Weight Loss Drugs Market Size & Forecast, By Mechanism of Action, 2021 – 2032
8.3.5.8.3 Weight Loss Drugs Market Size & Forecast, By Distribution Channel, 2021 – 2032
8.4 Asia-Pacific
8.4.1 Key Trends
8.4.2 Weight Loss Drugs Market Size & Forecast, By Drug Type, 2021 – 2032
8.4.3 Weight Loss Drugs Market Size & Forecast, By Mechanism of Action, 2021 – 2032
8.4.4 Weight Loss Drugs Market Size & Forecast, By Distribution Channel, 2021 – 2032
8.4.5 Weight Loss Drugs Market Size & Forecast, By Country, 2021 – 2032
8.4.5.1 China
8.4.5.1.1 Weight Loss Drugs Market Size & Forecast, By Drug Type, 2021 – 2032
8.4.5.1.2 Weight Loss Drugs Market Size & Forecast, By Mechanism of Action, 2021 – 2032
8.4.5.1.3 Weight Loss Drugs Market Size & Forecast, By Distribution Channel, 2021 – 2032
8.4.5.2 India
8.4.5.2.1 Weight Loss Drugs Market Size & Forecast, By Drug Type, 2021 – 2032
8.4.5.2.2 Weight Loss Drugs Market Size & Forecast, By Mechanism of Action, 2021 – 2032
8.4.5.2.3 Weight Loss Drugs Market Size & Forecast, By Distribution Channel, 2021 – 2032
8.4.5.3 Japan
8.4.5.3.1 Weight Loss Drugs Market Size & Forecast, By Drug Type, 2021 – 2032
8.4.5.3.2 Weight Loss Drugs Market Size & Forecast, By Mechanism of Action, 2021 – 2032
8.4.5.3.3 Weight Loss Drugs Market Size & Forecast, By Distribution Channel, 2021 – 2032
8.4.5.4 South Korea
8.4.5.4.1 Weight Loss Drugs Market Size & Forecast, By Drug Type, 2021 – 2032
8.4.5.4.2 Weight Loss Drugs Market Size & Forecast, By Mechanism of Action, 2021 – 2032
8.4.5.4.3 Weight Loss Drugs Market Size & Forecast, By Distribution Channel, 2021 – 2032
8.4.5.5 Australia
8.4.5.5.1 Weight Loss Drugs Market Size & Forecast, By Drug Type, 2021 – 2032
8.4.5.5.2 Weight Loss Drugs Market Size & Forecast, By Mechanism of Action, 2021 – 2032
8.4.5.5.3 Weight Loss Drugs Market Size & Forecast, By Distribution Channel, 2021 – 2032
8.4.5.6 ASEAN Countries
8.4.5.6.1 Weight Loss Drugs Market Size & Forecast, By Drug Type, 2021 – 2032
8.4.5.6.2 Weight Loss Drugs Market Size & Forecast, By Mechanism of Action, 2021 – 2032
8.4.5.6.3 Weight Loss Drugs Market Size & Forecast, By Distribution Channel, 2021 – 2032
8.4.5.7 Rest of Asia-Pacific
8.4.5.7.1 Weight Loss Drugs Market Size & Forecast, By Drug Type, 2021 – 2032
8.4.5.7.2 Weight Loss Drugs Market Size & Forecast, By Mechanism of Action, 2021 – 2032
8.4.5.7.3 Weight Loss Drugs Market Size & Forecast, By Distribution Channel, 2021 – 2032
8.5 Latin America
8.5.1 Key Trends
8.5.2 Weight Loss Drugs Market Size & Forecast, By Drug Type, 2021 – 2032
8.5.3 Weight Loss Drugs Market Size & Forecast, By Mechanism of Action, 2021 – 2032
8.5.4 Weight Loss Drugs Market Size & Forecast, By Distribution Channel, 2021 – 2032
8.5.5 Weight Loss Drugs Market Size & Forecast, By Country, 2021 – 2032
8.5.5.1 Brazil
8.5.5.1.1 Weight Loss Drugs Market Size & Forecast, By Drug Type, 2021 – 2032
8.5.5.1.2 Weight Loss Drugs Market Size & Forecast, By Mechanism of Action, 2021 – 2032
8.5.5.1.3 Weight Loss Drugs Market Size & Forecast, By Distribution Channel, 2021 – 2032
8.5.5.2 Argentina
8.5.5.2.1 Weight Loss Drugs Market Size & Forecast, By Drug Type, 2021 – 2032
8.5.5.2.2 Weight Loss Drugs Market Size & Forecast, By Mechanism of Action, 2021 – 2032
8.5.5.2.3 Weight Loss Drugs Market Size & Forecast, By Distribution Channel, 2021 – 2032
8.5.5.3 Mexico
8.5.5.3.1 Weight Loss Drugs Market Size & Forecast, By Drug Type, 2021 – 2032
8.5.5.3.2 Weight Loss Drugs Market Size & Forecast, By Mechanism of Action, 2021 – 2032
8.5.5.3.3 Weight Loss Drugs Market Size & Forecast, By Distribution Channel, 2021 – 2032
8.5.5.4 Colombia
8.5.5.4.1 Weight Loss Drugs Market Size & Forecast, By Drug Type, 2021 – 2032
8.5.5.4.2 Weight Loss Drugs Market Size & Forecast, By Mechanism of Action, 2021 – 2032
8.5.5.4.3 Weight Loss Drugs Market Size & Forecast, By Distribution Channel, 2021 – 2032
8.5.5.5 Rest of Latin America
8.5.5.5.1 Weight Loss Drugs Market Size & Forecast, By Drug Type, 2021 – 2032
8.5.5.5.2 Weight Loss Drugs Market Size & Forecast, By Mechanism of Action, 2021 – 2032
8.5.5.5.3 Weight Loss Drugs Market Size & Forecast, By Distribution Channel, 2021 – 2032
8.6 Middle East & Africa
8.6.1 Key Trends
8.6.2 Weight Loss Drugs Market Size & Forecast, By Drug Type, 2021 – 2032
8.6.3 Weight Loss Drugs Market Size & Forecast, By Mechanism of Action, 2021 – 2032
8.6.4 Weight Loss Drugs Market Size & Forecast, By Distribution Channel, 2021 – 2032
8.6.5 Weight Loss Drugs Market Size & Forecast, By Country, 2021 – 2032
8.6.5.1 UAE
8.6.5.1.1 Weight Loss Drugs Market Size & Forecast, By Drug Type, 2021 – 2032
8.6.5.1.2 Weight Loss Drugs Market Size & Forecast, By Mechanism of Action, 2021 – 2032
8.6.5.1.3 Weight Loss Drugs Market Size & Forecast, By Distribution Channel, 2021 – 2032
8.6.5.2 Saudi Arabia
8.6.5.2.1 Weight Loss Drugs Market Size & Forecast, By Drug Type, 2021 – 2032
8.6.5.2.2 Weight Loss Drugs Market Size & Forecast, By Mechanism of Action, 2021 – 2032
8.6.5.2.3 Weight Loss Drugs Market Size & Forecast, By Distribution Channel, 2021 – 2032
8.6.5.3 Qatar
8.6.5.3.1 Weight Loss Drugs Market Size & Forecast, By Drug Type, 2021 – 2032
8.6.5.3.2 Weight Loss Drugs Market Size & Forecast, By Mechanism of Action, 2021 – 2032
8.6.5.3.3 Weight Loss Drugs Market Size & Forecast, By Distribution Channel, 2021 – 2032
8.6.5.4 Egypt
8.6.5.4.1 Weight Loss Drugs Market Size & Forecast, By Drug Type, 2021 – 2032
8.6.5.4.2 Weight Loss Drugs Market Size & Forecast, By Mechanism of Action, 2021 – 2032
8.6.5.4.3 Weight Loss Drugs Market Size & Forecast, By Distribution Channel, 2021 – 2032
8.6.5.5 South Africa
8.6.5.5.1 Weight Loss Drugs Market Size & Forecast, By Drug Type, 2021 – 2032
8.6.5.5.2 Weight Loss Drugs Market Size & Forecast, By Mechanism of Action, 2021 – 2032
8.6.5.5.3 Weight Loss Drugs Market Size & Forecast, By Distribution Channel, 2021 – 2032
8.6.5.6 Rest of Middle East & Africa
8.6.5.6.1 Weight Loss Drugs Market Size & Forecast, By Drug Type, 2021 – 2032
8.6.5.6.2 Weight Loss Drugs Market Size & Forecast, By Mechanism of Action, 2021 – 2032
8.6.5.6.3 Weight Loss Drugs Market Size & Forecast, By Distribution Channel, 2021 – 2032
9. Competitive Landscape
9.1 Key Players' Positioning
9.2 Competitive Developments
9.2.1 Key Strategies Adopted (%), By Key Players, 2024
9.2.2 Year-Wise Strategies & Development, 2021 – 2025
9.2.3 Number Of Strategies Adopted By Key Players, 2024
9.3 Market Share Analysis, 2024
9.4 Product/Service & Application Benchmarking
9.4.1 Product/Service Specifications & Features By Key Players
9.4.2 Product/Service Heatmap By Key Players
9.4.3 Application Heatmap By Key Players
9.5 Industry Start-Up & Innovation Landscape
9.6 Key Company Profiles
9.6.1 Amgen Inc.
9.6.1.1 Company Overview & Snapshot
9.6.1.2 Product/Service Portfolio
9.6.1.3 Key Company Financials
9.6.1.4 SWOT Analysis
9.6.2 AstraZeneca.
9.6.2.1 Company Overview & Snapshot
9.6.2.2 Product/Service Portfolio
9.6.2.3 Key Company Financials
9.6.2.4 SWOT Analysis
9.6.3 Boehringer Ingelheim International GmbH
9.6.3.1 Company Overview & Snapshot
9.6.3.2 Product/Service Portfolio
9.6.3.3 Key Company Financials
9.6.3.4 SWOT Analysis
9.6.4 Currax Pharmaceuticals LLC.
9.6.4.1 Company Overview & Snapshot
9.6.4.2 Product/Service Portfolio
9.6.4.3 Key Company Financials
9.6.4.4 SWOT Analysis
9.6.5 Eisai Co., Ltd.
9.6.5.1 Company Overview & Snapshot
9.6.5.2 Product/Service Portfolio
9.6.5.3 Key Company Financials
9.6.5.4 SWOT Analysis
9.6.6 Eli Lilly and Company.
9.6.6.1 Company Overview & Snapshot
9.6.6.2 Product/Service Portfolio
9.6.6.3 Key Company Financials
9.6.6.4 SWOT Analysis
9.6.7 F. Hoffmann-La Roche Ltd (Roche Holding AG).
9.6.7.1 Company Overview & Snapshot
9.6.7.2 Product/Service Portfolio
9.6.7.3 Key Company Financials
9.6.7.4 SWOT Analysis
9.6.8 GlaxoSmithKline plc
9.6.8.1 Company Overview & Snapshot
9.6.8.2 Product/Service Portfolio
9.6.8.3 Key Company Financials
9.6.8.4 SWOT Analysis
9.6.9 Ionis Pharmaceuticals, Inc.
9.6.9.1 Company Overview & Snapshot
9.6.9.2 Product/Service Portfolio
9.6.9.3 Key Company Financials
9.6.9.4 SWOT Analysis
9.6.10 Johnson & Johnson.
9.6.10.1 Company Overview & Snapshot
9.6.10.2 Product/Service Portfolio
9.6.10.3 Key Company Financials
9.6.10.4 SWOT Analysis
9.6.11 Merck & Co., Inc.
9.6.11.1 Company Overview & Snapshot
9.6.11.2 Product/Service Portfolio
9.6.11.3 Key Company Financials
9.6.11.4 SWOT Analysis
9.6.12 Novartis AG
9.6.12.1 Company Overview & Snapshot
9.6.12.2 Product/Service Portfolio
9.6.12.3 Key Company Financials
9.6.12.4 SWOT Analysis
9.6.13 Novo Nordisk A/S.
9.6.13.1 Company Overview & Snapshot
9.6.13.2 Product/Service Portfolio
9.6.13.3 Key Company Financials
9.6.13.4 SWOT Analysis
9.6.14 Pfizer Inc.
9.6.14.1 Company Overview & Snapshot
9.6.14.2 Product/Service Portfolio
9.6.14.3 Key Company Financials
9.6.14.4 SWOT Analysis
9.6.15 Rhythm Pharmaceuticals, Inc.
9.6.15.1 Company Overview & Snapshot
9.6.15.2 Product/Service Portfolio
9.6.15.3 Key Company Financials
9.6.15.4 SWOT Analysis
9.6.16 Sanofi S.A.
9.6.16.1 Company Overview & Snapshot
9.6.16.2 Product/Service Portfolio
9.6.16.3 Key Company Financials
9.6.16.4 SWOT Analysis
9.6.17 Takeda Pharmaceutical Company Limited.
9.6.17.1 Company Overview & Snapshot
9.6.17.2 Product/Service Portfolio
9.6.17.3 Key Company Financials
9.6.17.4 SWOT Analysis
9.6.18 Teva Pharmaceutical Industries Ltd.
9.6.18.1 Company Overview & Snapshot
9.6.18.2 Product/Service Portfolio
9.6.18.3 Key Company Financials
9.6.18.4 SWOT Analysis
9.6.19 VIVUS, Inc.
9.6.19.1 Company Overview & Snapshot
9.6.19.2 Product/Service Portfolio
9.6.19.3 Key Company Financials
9.6.19.4 SWOT Analysis
9.6.20 Zafgen, Inc.
9.6.20.1 Company Overview & Snapshot
9.6.20.2 Product/Service Portfolio
9.6.20.3 Key Company Financials
9.6.20.4 SWOT Analysis
10. Analyst Recommendations
10.1 SNS Insider Opportunity Map
10.2 Industry Low-Hanging Fruit Assessment
10.3 Market Entry & Growth Strategy
10.4 Analyst Viewpoint & Suggestions On Market Growth
11. Assumptions
12. Disclaimer
13. Appendix
13.1 List Of Tables
13.2 List Of Figures
